Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...
A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...
Prevention is always better than cure, particularly with potentially life-threatening diseases. But when dealing with an ...
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...
On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...
(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a ...
Magnetic resonance imaging (MRI) holds great potential to spare men with suspected prostate cancer a painful biopsy. In our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback